Kupando Secures Additional €10 Million in Series A Financing to Advance Novel Immuno-Oncology and Infectious Diseases Programs
Kupando raised an additional €10 million in Series A financing, bringing the total Series A funding to €23 million. Investment again led by Remiges Ventures, co-led by LifeCare Partners, with participation from all existing investors and new investor…